← Back to headlines
Revolution Medicines' Pancreatic Cancer Drug Shows Success in Late-Stage Trial
Revolution Medicines announced that its highly anticipated drug for pancreatic cancer has succeeded in a Phase 3 clinical trial. This represents a potential breakthrough in treating the aggressive disease.
13 Apr, 12:04 — 13 Apr, 12:04
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Study Reveals Early Human Quarrying in South Africa 220,000 Years Ago
just now
CSIR Scientist Advocates Community-Driven Approach to Combat Illegal Mining in Ghana
8m ago
Reader's Opinion: English as the Universal Language of Science
15m ago